This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Kidney Transplantation or Renal Transplantation
and you are
between 18 and 65
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study was to assess whether a new drug, Nulojix® (belatacept), would minimize serious long term side effects associated with anti-rejection medications while still protecting the new kidney from damage. The researchers also wanted to learn more about the safety of this treatment and long term health of the transplanted kidney.

Provided treatments

  • Drug: Alemtuzumab
  • Drug: MMF
  • Biological: Basiliximab
  • Drug: Short-term Tac
  • Drug: tacrolimus
  • Biological: Belatacept
  • Drug: methylprednisolone

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01436305. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 19 volunteers for the current phase.
Official trial title:
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)